CClinicalTrials.gg
CompletedNCT07129668FIKVOXUpdated Aug 19, 2025

Effects of Finger Kazoo Exercise With and Without Oropharyngeal Enlargement in the Operatic Singing Voice

An interventional study of Condition A and Condition B in Voice Alteration, sponsored by Aveiro University. Completed at 1 site in Portugal. Open to participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-08-19.

Sponsored by Aveiro University · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Randomized
Ages
18 Years to 55 Years
Sex
All
01

Study summary

This clinical trial aimed to evaluate the effects of the semi-occluded vocal tract exercise Finger Kazoo (FK), with and without oropharyngeal expansion, on the singing voice. Fifteen classically trained singers, screened using the Singing Voice Handicap Index-10 (SVHI-10), participated in a randomized, single-blind, crossover trial with two experimental sessions separated by 48 hours. Participants were randomized via Sealed Envelope to start in Condition A (without oropharyngeal expansion) or Condition B (with oropharyngeal expansion). In each session, standardized recordings were obtained before and after the intervention, including maximum phonation time for the vowels /a/ and /i/, and an operatic aria excerpt. Acoustic analysis (PRAAT) extracted fundamental frequency (F0), jitter, and shimmer. Comparisons between baseline and experimental conditions were performed using paired-samples t-tests, Wilcoxon tests, robust paired t-tests, and Friedman ANOVA with Durbin-Conover, Tukey, Bonferroni, and Holm post hoc corrections, with a 95% confidence interval. Auditory-perceptual evaluation was conducted by 15 blinded experts using the EAI Scale Form, with balanced sample distribution among raters. Self-perceptual evaluation was also performed by participants using the same scale.

02

Conditions studied

  • Voice Alteration

Browse trials for

Keywords

  • Singing Voice
  • Finger Kazoo
  • SOVTE
  • Operatic Voice
03

In context

Dysphonia

131 studies on the registry are indexed under Dysphonia; 34 are open to participants now.

This study's enrollment of 15 is below the median of 39 across 94 interventional studies indexed under Dysphonia.

Browse Dysphonia studies →

Lead sponsor

Aveiro University is the lead sponsor of 57 studies on the registry; 13 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Classically trained singers aged 18 to 45 years.
  • Scoring below the cutoff for vocal handicap on the Singing Voice Handicap Index-10 (SVHI-10 ≤ 6 )*.
  • No history of recently vocal fold pathology or laryngeal surgery.
  • Non-smokers and no current upper respiratory infection.
  • Willingness and ability to attend two experimental sessions spaced 48 hours apart.

Exclusion criteria

Exclusion Criteria:

  • Presence of any current voice disorder or history of chronic laryngeal disease.
  • Recent respiratory infection within 2 weeks prior to enrollment.
  • Use of medications affecting voice or respiratory function.
  • Inability or unwillingness to comply with study protocol.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
15 participants (actual)

Study arms

  • Active comparator
    Condition A

    Without Oropharyngeal Enlargement

    Behavioral: Condition A · Behavioral: Condition B

  • Active comparator
    Condition B

    With Oropharyngeal Enlargement

    Behavioral: Condition A · Behavioral: Condition B

  • Active comparator
    Condition 0 or Baseline

    Condition 0 (Baseline) consists of producing the target vocal tasks without any semi-occlusion or intentional oropharyngeal modification just a pre vocal warmup.

    Behavioral: Condition A · Behavioral: Condition B

Interventions

  • BehavioralCondition A

    Condition A consists of performing the Finger Kazoo exercise without inducing oropharyngeal enlargement. In this condition, participants place the index finger vertically in front of the lips to partially occlude the vocal tract, producing a semi-occluded vocal tract configuration, but without modifying tongue position, soft palate height, or pharyngeal wall expansion to increase the oropharyngeal space.

    Also known as: Whitout Oropharyngeal Enlargement

  • BehavioralCondition B

    Condition B consists of performing the Finger Kazoo exercise with intentional oropharyngeal enlargement. In this condition, participants place the index finger vertically in front of the lips to partially occlude the vocal tract, producing a semi-occluded vocal tract configuration, while simultaneously modifying tongue position, elevating the soft palate, and expanding the pharyngeal walls to increase the oropharyngeal space.

    Also known as: With Oropharyngeal Enlargement

06

What researchers measure

Primary outcomes

  1. Maximum Phonation Time (MPT) variation between conditions without and with oropharyngeal enlargement.

    Assessment of the difference in maximum phonation time (in seconds) between two experimental conditions: without oropharyngeal enlargement (Condition A) and with oropharyngeal enlargement (Condition B), during sustained vowel phonation. Data Collection Method: Acoustic recordings obtained using Praat software. The MPT was measured from the onset of phonation to cessation, with participants instructed to sustain the vowel at comfortable pitch and loudness. Analysis Method: Robust Paired Samples T-Test comparing MPT between Condition A and Condition B. Effect sizes calculated using Cohen's d. Results Summary: Mean MPT was significantly higher in Condition B (+7.9 s; p \< .001; d = 0.46), indicating improved phonatory efficiency.

    Time frame: Baseline and 48 hours after first session (allowing return to baseline before second session).

Secondary outcomes

  1. Change in Fundamental Frequency Stability (ΔF0) between conditions without and with oropharyngeal enlargement.

    Evaluation of the mean variation in fundamental frequency (in Hz) from onset to end of sustained vowel phonation, comparing Condition A and Condition B. Data Collection Method: Praat software pitch analysis, extracting F0 mean values for initial and final 3 seconds of the sustained vowel, then calculating the difference (ΔF0). Analysis Method: Robust Paired Samples T-Test. Results Summary: ΔF0 was significantly lower in Condition B (-7.6 Hz; p \< .001; d = 0.39), indicating greater pitch stability.

    Time frame: Baseline and 48 hours after first session (allowing return to baseline before second session).

Other outcomes

  1. Change in Jitter between conditions without and with oropharyngeal enlargement.

    Percentage variation in jitter between the initial and final segments of sustained vowel phonation. Data Collection Method: Jitter (%) extracted from Praat software and compared between initial and final segments. ΔJitter calculated as final - initial. Analysis Method: Robust Paired Samples T-Test. Results Summary: ΔJitter was significantly reduced in Condition B (-1.3%; p \< .001; d = 0.54), indicating improved micro-frequency stability.

    Time frame: Baseline and 48 hours after first session (allowing return to baseline before second session).

  2. Change in Shimmer between conditions without and with oropharyngeal enlargement.

    Percentage variation in shimmer between the initial and final segments of sustained vowel phonation. Data Collection Method: Shimmer (%) extracted from Praat software and compared between initial and final segments. ΔShimmer calculated as final - initial. Analysis Method: Robust Paired Samples T-Test. Results Summary: ΔShimmer was significantly reduced in Condition B (-2.1%; p \< .001; d = 0.57), suggesting improved amplitude stability.

    Time frame: Baseline and 48 hours after first session (allowing return to baseline before second session).

07

Study locations

1 site
  • Essua - University of Aveiro
    Aveiro, Aveiro District 3810-193, Portugal
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared due to institutional and legal restrictions on data privacy and protection as per the data protection agreement signed with the University of Aveiro.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 19, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07129668
Lead sponsor
Aveiro University
Collaborators
School of Health Sciences, University of Aveiro (ESSUA)
Responsible party
Jean Carlos Gorges (Principal Investigator, Aveiro University) — Principal investigator
First posted
Aug 19, 2025
Start date
May 30, 2025
Primary completion
Jul 24, 2025
Completion
Jul 26, 2025
Last update
Aug 19, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion